memantine has been researched along with Atherosclerotic Parkinsonism in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " After memantine was started he developed severe fluctuations in awareness, visual hallucinations, agitation, and worsened parkinsonism." | 3.73 | Exacerbation of Lewy bodies dementia due to memantine. ( Blazquez-Menes, B; Calatayud, MT; Menendez-Gonzalez, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, K | 1 |
| Ikeda, K | 1 |
| Mizumura, S | 1 |
| Tachiki, K | 1 |
| Yanagihashi, M | 1 |
| Iwasaki, Y | 1 |
| Tronci, E | 1 |
| Fidalgo, C | 1 |
| Zianni, E | 1 |
| Collu, M | 1 |
| Stancampiano, R | 1 |
| Morelli, M | 1 |
| Gardoni, F | 1 |
| Carta, M | 1 |
| Menendez-Gonzalez, M | 1 |
| Calatayud, MT | 1 |
| Blazquez-Menes, B | 1 |
| Danysz, W | 1 |
| Parsons, CG | 1 |
| Kornhuber, J | 1 |
| Schmidt, WJ | 1 |
| Quack, G | 1 |
| Kucheryanu, VG | 1 |
| Kryzhanovskii, GN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Memantine for Enhanced Stroke Recovery[NCT02144584] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2014-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for memantine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.
Topics: Amantadine; Animals; Antiparkinson Agents; Excitatory Amino Acid Antagonists; Memantine; Parkinson D | 1997 |
4 other studies available for memantine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Combined treatment of methylprednisolone pulse and memantine hydrochloride prompts recovery from neurological dysfunction and cerebral hypoperfusion in carbon monoxide poisoning: a case report.
Topics: Antiparkinson Agents; Carbon Monoxide Poisoning; Cerebrovascular Circulation; Cerebrovascular Disord | 2014 |
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: Amantadine; Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesias; Excitatory Amino Aci | 2014 |
Exacerbation of Lewy bodies dementia due to memantine.
Topics: Aged; Alzheimer Disease; Dopamine Agonists; Hallucinations; Humans; Lewy Body Disease; Male; Memanti | 2005 |
Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Excitatory Amino Acid Antagonists; Glutamic A | 2000 |